HeartSciences Inc.
HSCS
$3.05
$0.0852.87%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 14.70K | 3.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 14.70K | 3.90K |
| Cost of Revenue | -- | -- | 0.00 | 4.60K | 1.50K |
| Gross Profit | -- | -- | 0.00 | 10.10K | 2.40K |
| SG&A Expenses | 786.10K | 850.70K | 833.70K | 1.03M | 815.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.99M | 2.08M | 1.88M | 1.54M | 1.57M |
| Operating Income | -1.99M | -2.08M | -1.88M | -1.53M | -1.57M |
| Income Before Tax | -2.08M | -2.05M | -1.85M | -1.64M | -1.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.08M | -2.05M | -1.85M | -1.64M | -1.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.08M | -2.05M | -1.85M | -1.64M | -1.75M |
| EBIT | -1.99M | -2.08M | -1.88M | -1.53M | -1.57M |
| EBITDA | -1.97M | -2.06M | -1.87M | -1.52M | -1.56M |
| EPS Basic | -2.27 | -2.64 | -2.82 | -3.06 | -15.92 |
| Normalized Basic EPS | -1.42 | -1.65 | -1.76 | -1.91 | -9.95 |
| EPS Diluted | -2.27 | -2.64 | -2.82 | -3.06 | -15.92 |
| Normalized Diluted EPS | -1.42 | -1.65 | -1.76 | -1.91 | -9.95 |
| Average Basic Shares Outstanding | 917.40K | 777.70K | 654.10K | 537.90K | 109.80K |
| Average Diluted Shares Outstanding | 917.40K | 777.70K | 654.10K | 537.90K | 109.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
